Organogenesis Holdings Stock In The News

ORGO Stock  USD 4.92  0.03  0.61%   
Our overall analysis of Organogenesis Holdings' news coverage and content from conventional and social sources shows investors' bearish mood towards Organogenesis Holdings. The specific impact of Organogenesis Holdings news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Organogenesis Holdings' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Organogenesis Holdings headlines in addition to utilizing other, more conventional financial analysis modules. Check out Organogenesis Holdings Backtesting and Organogenesis Holdings Hype Analysis.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.

Organogenesis Holdings Today Top News and Investor Outlook

Yahoo News
Discovering Opportunities: 3 Penny Stocks With Market Caps Over $200M
https://finance.yahoo.com/news/discovering-opportunities-3-penny-stocks-120512349.html
 Bullish
seekingalpha News
Biggest stock movers Tuesday: NVDA, TTD, and more
https://seekingalpha.com/news/4467340-biggest-stock-movers-tuesday?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
seekingalpha News
CMS proposed payment rule aims to cut waste, boost chronic disease management
https://seekingalpha.com/news/4467277-cms-proposed-payment-rule-aims-to-cut-waste-boost-chronic-disease-management?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
 Neutral
Yahoo News
Organogenesis Holdings Leads The Charge With 2 Other Promising Penny Stocks
https://finance.yahoo.com/news/organogenesis-holdings-leads-charge-2-120508128.html
 Bullish
nasdaq News
Monday 6/9 Insider Buying Report: AMPY, ORGO
https://www.nasdaq.com/articles/monday-6-9-insider-buying-report-ampy-orgo
 Bullish
Yahoo News
High Growth Tech Stocks To Watch In The US Market
https://finance.yahoo.com/news/high-growth-tech-stocks-watch-113813002.html
 Bullish
Yahoo News
Top Growth Companies With High Insider Ownership May 2025
https://finance.yahoo.com/news/top-growth-companies-high-insider-173534385.html
 Bullish
Yahoo News
Discovering Opportunities: 3 Penny Stocks With Market Caps Over $500M
https://finance.yahoo.com/news/discovering-opportunities-3-penny-stocks-180505060.html
 Bullish
Macroaxis News: globenewswire.com
Organogenesis Supports CMS’ Local Covera...
https://www.globenewswire.com/news-release/2025/04/11/3060329/0/en/Organogenesis-Supports-CMS-Local-Coverage-Determination-Implementation-Delay-to-Review-Coverage-Policies-to-Maintain-Patient-Access-with-High-Quality-Evidence-of-Effectiveness.html
 Bullish
Macroaxis News: globenewswire.com
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
https://www.globenewswire.com/news-release/2025/04/07/3057201/0/en/Organogenesis-Holdings-Inc-to-Report-First-Quarter-of-Fiscal-Year-2025-Financial-Results-on-May-8-2025.html
 Bullish

Organogenesis Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Organogenesis and other traded companies coverage with news coverage. We help investors stay connected with Organogenesis headlines for the 13th of August 2025 to make an informed investment decision based on correlating the impacts of news items on Organogenesis Stock performance. Please note that trading solely based on the Organogenesis Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Organogenesis Holdings' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Organogenesis Holdings investors visualize upcoming and past events in order to time the market based on Organogenesis Holdings noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Organogenesis Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Organogenesis Holdings' short interest history, or implied volatility extrapolated from Organogenesis Holdings options trading.
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out Organogenesis Holdings Backtesting and Organogenesis Holdings Hype Analysis.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.5
Earnings Share
(0.14)
Revenue Per Share
3.334
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.02)
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.